Article info
PDFClinical science
Risk factors of recurrence of macular oedema associated with branch retinal vein occlusion after intravitreal bevacizumab injection
- Correspondence to Dr Seong-Woo Kim, Department of Ophthalmology, Korea University Ansan Hospital, 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do 425-707, South Korea; ksw64723{at}korea.ac.kr
Citation
Risk factors of recurrence of macular oedema associated with branch retinal vein occlusion after intravitreal bevacizumab injection
Publication history
- Received October 9, 2016
- Revised December 26, 2016
- Accepted January 30, 2017
- First published February 23, 2017.
Online issue publication
December 07, 2017
Article Versions
- Previous version (26 September 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/